Abstract
Purpose: Extremely low birth weight (ELBW, < 1000g) infants are at risk for prolonged assisted ventilation, elevating risk for lung injury, bronchopulmonary dysplasia (BPD) and death. Furosemide and bumetanide are diuretics used to reduce respiratory support. Use of diuretics in ELBW infants is off-label; safety and efficacy is unknown. The objective of this study is to compare the incidence of clinical outcomes in ELBW infants at 2 neonatal intensive care units (NICUs) with different furosemide and bumetanide prescribing …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
